Liyan Mazahreh

Researcher

University of Arkansas for Medical Sciences

faculty

2 h-index 12 pubs 130 cited

Research Areas

Multiple Myeloma Research and Treatments Immune Response and Inflammation Cancer Treatment and Pharmacology Meta-analysis and systematic reviews Child and Adolescent Health Asthma and respiratory diseases Microbial infections and disease research

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Liyan Mazahreh's research focuses on clinical outcomes and therapeutic strategies across various medical conditions. Recent publications investigate the risk of infections associated with bispecific antibodies in multiple myeloma, drawing on pooled analyses. Other work explores tumor response to immune-oncology therapy in patients with complex conditions, such as papillary renal cell carcinoma and immune-related myasthenia gravis. Mazahreh has also examined hospitalizations and the severity of asthma exacerbations in children during non-pharmaceutical interventions and investigated advancements in eosinophilic chronic rhinosinusitis. Additionally, research includes evaluating the duration of immune checkpoint inhibitors in oncology and the potential for ongoing radiographic response without continued dosing.

Mazahreh collaborates with several researchers at the University of Arkansas for Medical Sciences, including Farah Mazahreh, A. Mazin Safar, Fenghuang Zhan, and Sharmilan Thanendrarajan, with whom they have co-authored multiple publications. Mazahreh's scholarly output includes 12 publications and has garnered 130 citations, with an h-index of 2. The researcher remains active, with publications dating up to 2026.

Metrics

  • h-index: 2
  • Publications: 12
  • Citations: 130

Selected Publications

  • Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions (2026) DOI
  • Exploring new frontiers in eosinophilic chronic rhinosinusitis (2025) DOI
  • Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better (2025) DOI
  • Ongoing Radiographic Response for Over 20 Months in Metastatic Cancer Without Continued Immune Checkpoint Inhibitor (ICI) Dosing (2025) DOI
  • Tumor Response to Immune-Oncology Therapy Despite High-Dose Steroid Intervention in a Patient With Papillary Renal Cell Carcinoma and Immune-Related Myasthenia Gravis (2025) DOI
  • Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications (2024) DOI

Collaborators

Researchers in the database who share publications

Farah Mazahreh University of Arkansas for Medical Sciences 8 shared publications A. Mazin Safar University of Arkansas for Medical Sciences 4 shared publications Fenghuang Zhan University of Arkansas for Medical Sciences 2 shared publications Sharmilan Thanendrarajan University of Arkansas for Medical Sciences 2 shared publications John D. Shaughnessy Jr. University of Arkansas for Medical Sciences 2 shared publications Samer Al Hadidi University of Arkansas for Medical Sciences 2 shared publications Carolina Schinke University of Arkansas for Medical Sciences 2 shared publications Maurizio Zangari University of Arkansas for Medical Sciences 2 shared publications

Similar Researchers

Based on overlapping research topics

Hira Imad Cheema University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Immune Response and Inflammation Cancer Treatment and Pharmacology
Good match 5 shared topics
A. G. P. Brown University of Arkansas for Medical Sciences
Immune Response and Inflammation Cancer Treatment and Pharmacology Meta-analysis and systematic reviews
Good match 4 shared topics
Shahwar Yousuf University of Arkansas for Medical Sciences
Immune Response and Inflammation Meta-analysis and systematic reviews Child and Adolescent Health
Good match 5 shared topics
Carolina Schinke University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Immune Response and Inflammation Cancer Treatment and Pharmacology
Good match 4 shared topics
Maurizio Zangari University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Immune Response and Inflammation Cancer Treatment and Pharmacology
Good match 4 shared topics
Farah Mazahreh University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Cancer Treatment and Pharmacology Meta-analysis and systematic reviews
Good match 4 shared topics